Skip to Main Content

Paper Details

Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.
Clin Gastroenterol Hepatol
89
2014
25(OH), 25(OH)D, 25-hydroxy vitamin D, 25[OH]D, Crohn's disease, IBD, Patients, Vitamin D, Vitamin D deficiency, cancer, cancers, colorectal cancer, inflammatory bowel diseases, lung cancer, nonmelanoma skin cancer, patients, ulcerative colitis, vitamin D, vitamin D deficiency
Author NameAffiliation
Ashwin N AnanthakrishnanMassachusetts General Hospital, Massachusetts Harvard Medical School
Tianxi CaiHarvard School of Public Health
Tianxi CaiHarvard School of Public Health
Vivian S Gainer
Peter SzolovitsMassachusetts Institute of Technology
Peter SzolovitsMassachusetts Institute of Technology
Susanne Churchilli2b2 National Center for Biomedical Computing, Brigham and Women's Hospital
Susanne Churchilli2b2 National Center for Biomedical Computing, Brigham and Women's Hospital
Elizabeth W KarlsonHarvard Medical School, Brigham and Women's Hospital
Elizabeth W KarlsonHarvard Medical School, Brigham and Women's Hospital
Shawn N MurphyHarvard Medical School, Massachusetts General Hospital
Shawn N MurphyHarvard Medical School, Massachusetts General Hospital
Isaac S KohaneHarvard Medical School, Massachusetts Children's Hospital Boston, Massachusetts i2b2 National Center for Biomedical Computing, Brigham and Women's Hospital
Isaac S KohaneHarvard Medical School, Massachusetts Children's Hospital Boston, Massachusetts i2b2 National Center for Biomedical Computing, Brigham and Women's Hospital
Katherine P LiaoHarvard Medical School, Brigham and Women's Hospital
  • 1 - 15

Datasets